Abbott (NYSE:ABT) faces a proposed class action lawsuit related to alleged tracking tools used with its FreeStyle Libre ...

Abbott Laboratories' (NYSE: ABT) business has been a bit of a roller coaster. The pandemic disrupted its medical device ...

DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

Abbott Laboratories' diabetes ... CGM option for type 2 diabetes patients who do not use insulin (the FreeStyle Libre targets insulin and non-insulin users). A simpler, more targeted option ...

Foreign exchange fluctuation is a major headwind for ABT, as a considerable percentage of its revenues comes from outside the ...

Over the past few years, Abbott Laboratories' (NYSE ... CGM option for type 2 diabetes patients who do not use insulin (the FreeStyle Libre targets insulin and non-insulin users).

A parenting expert has given five top tips to help parents adjust to a quieter household as millions of students prepare to ...

So, while you should always follow the fundamentals of healthy living – like exercising and eating a balanced diet – ...

Piper Sandler initiated coverage on Abbott Laboratories (NYSE: ABT) with an "overweight" rating and a price target of $131 ...

Thursday, Abbott Laboratories (NYSE:ABT) said it is recalling some FreeStyle Libre 3 sensors after finding that a small ... Dexcom’s Stelo Device Brings Affordable Continuous Glucose Monitoring To ...

Thursday, Abbott Laboratories ABT said it is recalling some FreeStyle Libre 3 sensors after finding ... Continuous Glucose Monitoring To Type 2 Diabetes Patients. This recall involves removing ...